Vistagen Therapeutics, Inc. VTGN 深 沪
交易中 03-25 11:44:41 美东时间
0.6299
+0.014
+2.21%
华盛通- 最 高0.6507
- 今 开0.6208
- 成交量 30.33万股
- 最 低 0.6208
- 昨 收 0.6163
- 总市值 2495.68万
- 52周最高 5.14
- 市盈率 静 --
- 换手率 0.77%
- 52周最低 0.43
- 委 比 -66.67%
- 总股本 3962.03万
- 历史最高 495.00
- 量 比 2.84
- 振 幅 4.85%
- 历史最低 0.43
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多VistaGen Showcases Intranasal Pherine Pipeline in New Presentation
The latest update is out from VistaGen Therapeutics ( ($VTGN) ). On March 16, 2...
03-17 04:29
Class action lawsuit targets VistaGen Therapeutics over alleged misleading clinical trial statements
Class action lawsuit targets VistaGen Therapeutics over alleged misleading clinical trial statements A securities class action lawsuit has been filed against VistaGen on behalf of shareholders who purchased securities between April 1, 2024 and December 16, 2025. The complaint alleges the company mad
03-11 21:03
BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction
BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction March 11 (Reuters) - VistaGen Therapeutics Inc VTGN.O : VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILING VISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLIN
03-11 19:14
Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints
Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pressure on the stock.
03-05 23:38
VistaGen Investors Face March 16 Deadline to Lead Securities Class Action
VistaGen Investors Face March 16 Deadline to Lead Securities Class Action Faruqi and Faruqi, LLP is investigating potential claims against VistaGen Therapeutics Inc. and has reminded investors of a March 16, 2026 deadline to seek lead-plaintiff status in a federal securities class action. The compla
03-03 21:41
VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum
VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum VistaGen Therapeutics Inc. will participate in the Leerink Healthcare Conference in Miami, Florida, March 9-11, 2026, featuring one-on-one meetings. It will also join the Stifel 2026 Virtual CNS Forum on March
03-03 21:30
Levi & Korsinsky Files Securities Class Action Against VistaGen Therapeutics
Levi & Korsinsky Files Securities Class Action Against VistaGen Therapeutics Levi & Korsinsky has filed a securities class action lawsuit against VistaGen Therapeutics Inc. on behalf of investors who purchased shares between April 1, 2024 and December 16, 2025. The complaint alleges the company made
02-24 05:18
VistaGen Director Paul Edick Resigns from Board
VistaGen Director Paul Edick Resigns from Board VistaGen Therapeutics Inc. said board member Paul Edick resigned from its Board of Directors on Feb. 13, 2026. The company said it is actively seeking candidates to fill the vacancy. Disclaimer: This news brief was created by Public Technologies (PUBT)
02-20 22:12
Class Action Targets VistaGen After 80% Stock Plunge
Class Action Targets VistaGen After 80% Stock Plunge Levi & Korsinsky, LLP has filed a proposed class action seeking damages for investors who bought VistaGen Therapeutics securities between April 1, 2024 and December 16, 2025. The suit follows a sharp stock drop after the company reported its Phase
02-18 22:02
VistaGen Therapeutics Faces Investor Class Action Over Failed Drug Trial
VistaGen Therapeutics Faces Investor Class Action Over Failed Drug Trial A class action lawsuit has been filed against VistaGen Therapeutics Inc. on behalf of investors who purchased the company’s common stock between April 1, 2024 and December 16, 2025. The litigation alleges that VistaGen made fal
02-14 02:18
